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При проведенні мультиваріантного аналізу ризик пізніх 
подій після АКШ був у 6,24 разу більшим у пацієнтів, які 
не приймали статини через рік після АКШ, порівняно з 
особами, що застосовували ці препарати (95 % ДІ 2,313–
16,809); р<0,001)). Незалежними предикторами виникнен-
ня пізніх подій виявились також післяопераційне застосу-
вання петльових діуретиків (ВШ 2,186 (95 % ДІ 1,187–
4,024); р=0,012) та гірший показник рШКФ при випису-
ванні зі стаціонару (ВШ 1,366 (95 % ДІ 1,007–1,853); 
р=0,045).
Висновки. Незалежний зв’язок виникнення пізніх 
подій зі зниженою функцією нирок, застосуванням петльо-
вих діуретиків та відсутністю терапії статинами повинен 
враховуватися при визначенні кратності спостереження та 
пріоритетів післяопераційного ведення хворих.
Relation of serum nesfatin-1 levels 
to silent myocardial ischemia 
in hypertensive patients
S.V. Ivanchenko, O.M. Kovaleva 
Kharkiv National Medical University, Kharkiv, Ukraine
Nesafatin-1 is a peptide containing 82 amino acids that is 
synthesized both in the hypothalamus and in the peripheral 
adipose tissue. During the last decade, a number of studies have 
proven the anti-inflammatory effect of this cytokine. According 
to C.H. Tang et al., 2012, increase of nesfatin-1 level reduces 
the expression of inflammatory genes, including tumor necrosis 
factor-α, interleukin-1β and IL-6 in brain tissue damage in rats. 
Bonnet et al., 2009, investigated the relationship between 
inflammation of the brain and the hypothalamus and activation 
of the nesfatin-1 expressing neuron. In a study by Ayada et al., 
2016, it was shown that intravenous administration of nes-
fatin-1 leads to vasoconstriction by inhibiting the synthesis of 
nitric oxide and increases arterial pressure. Thus, it is possible 
to assume that the decrease in the expression of nesfatin-1 
might have a role in the pathogenesis of endothelial dysfunc-
tion and acute cardiac events.
The purpose of the study: to analyze the relation between 
the serum level of nesfatin-1 and the presence of silent myocar-
dial ischemia in patients with hypertension (HT).
Material and methods: 86 patients with HT underwent 
24-hour ECG monitoring. Patients were divided into 2 groups: 
the first one – 68 people without signs of ischemia. The second 
group included 18 subjects (21.1 %) with ST segment depres-
sion (maximum 2.7 mm for men and 3.7 mm for women). The 
control group included 12 practically healthy persons adjusted 
by gender and age. The serum level of nesfatin-1 was deter-
mined by the immune enzyme method using the Human 
Nesfatin-1 ELISA Kit (Kono Biotech Co., Ltd., PRC). 
Statistical analysis of data was performed using Statistica 6.1 
software package for the statistical information processing 
(Statsoft Inc., USA). Quantitative attributes are presented as 
median (Me), values of the upper (UQ) and lower (LQ) quar-
tiles.
Results. An intergroup analysis did not reveal a statisti-
cally significant difference in age, body mass index, blood pres-
sure (systolic and diastolic), diabetes status and smoking sta-
tus. The serum levels of nesfatin-1 in patients without symp-
toms of ischemia were 7.32 (5.21; 8.2) ng/ml, which was sig-
nificantly higher than in the second group – 5.01 (3.28; 6.44) 
ng/ml (p=0.03) and in the control group – 4.54 (4.24; 4.87) 
ng/ml (p=0.01). At the same time, the content of nesfatin-1 in 
patients with ischemia was not significantly different from that 
in the control group (p=0.06)
Conclusions. the level of serum nesfatin-1 was significant-
ly elevated in patients with hypertension. Low levels of the 
cytokine in patients within this cohort were associated with 
the presence of ischemia at 24h ECG monitoring and could be 
a marker of an unfavorable course of disease.
Atherosclerotic changes in coronary 
and cerebral vessels in patients 
with coronary heart disease
Y. Kushnir, K. Perepelytsia
SI «Dnipropetrovsk Medical Academy 
of the Ministry of Health of Ukraine», Dnipro, Ukraine
The aim of the study was to assess atherosclerotic changes 
in coronary and cerebral vessels in patients with coro-
nary heart disease (CHD).
Methods: 124 patients with CHD were enrolled: 71.8 
% men and 28.2 % women. 
Transcranial doppler ultrasonography study of head and 
neck arteries was performed to 58.1 % of patients. Cerebral 
angiography and coronary angiography were done to all 
patient (100 %).
Results. The results of trascranial doppler (TCD) ultra-
sonography showed that all pts (100 %) had stenosis and 
79.2 % pts had 2 stenosis. These data were confirmed with 
cerebral angiography in 93.1 % pts. Аll patients (100 %) who 
had coronary artery stenosis at the same time had cerebral 
artery stenosis. Patients who haven’t been detected stenosis 
with cerebral angiography didn’t have stenosis in coronary 
angiography as well. However, 32.8 % of patients with cere-
bral artery stenosis did not have atherosclerotic changes in 
the coronary arteries. According to the results of coronary 
angiography stenosis had 62.9 % patients, including 2 steno-
sis in 37.9 % cases. Stenosis of right coronary artery had 
38.7 % patients (77 % of them were hemodynamically signifi-
cant 75 %), stenosis of anterior interventricular branch had 
37.1 % patients (65 % of them had hemodynamically signifi-
cant stenosis 75 %).
Conclusions. Coronary heart disease is associated with 
multifocal atherosclerosis and stenosis in both coronary and 
cerebral arteries. Meanwhile, most of patients had hemody-
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namically significant stenosis. The gender fea-
tures of the existence of cerebral and coronary artery steno-
sis were established, advantage of men. It was deter-
mine that cerebral artery stenosis is not always associat-
ed with coronary stenosis.
The link between ischemic heart disease 
risk factors, platelet dysfunction 
and aspirin resistance
Y.H. Kyyak, O.Ye. Labinska, M.P. Halkevych, 
H.Y. Kyyak, O.Y. Barnett 
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Aspirin resistance (AR) most often occurs in ischemic 
heart disease (IHD) patients with risk factors such as heredity, 
senile age, sex, diabetes mellitus (DM), hypertension, obesity, 
occupational hazards and smoking. Aspirin prevents platelet 
(Pl) aggregation with their preserved functional capacity. The 
signs of decreased Pl reactivity deserves further research.
Purpose. To evaluate thrombocyte ultrastructure and 
function in patients with ACS in order to reveal the mechanism 
of AR.
Methods. In the study were included 38 patients with the 
history of acute myocardial infarction (AMI) admitted to the 
cardiology department of Lviv Clinical Emergency Care 
Hospital during the last 5 years. The Pl were isolated by cen-
trifugation of citrate blood, separated and subseguently fixed 
in 1 % solution OsO4 according to Barkagan’s method (1999 
yr). Pl ultrastructural examined by electron microscopy 
(×6000).
Results. Patients were divided into 2 groups. The main 
group was a cohort of 28 patients with clinical evidence of AR 
(19 males and 9 females, average age 54 years±12 (range 42–68 
yr.). These persons had different IHD risk factors and features 
of ACS, such as repeated AMI, stent thrombosis. The control 
group comprised 10 patients with uncomplicated AMI without 
clinical evidence of AR, average age 64 years±12 (range 52–78 
yr.). In the patients of control group 90 % of Pl were activated, 
with pseudopodia presence and thrombocyte granules concen-
tration in their central part, with clearly preserved functional 
capacity. In the main group 80 % of Pl were aggregated, osmi-
ofilic, vacuolyzed with pseudopodia microclasmatosis and 
showed evidence of calcification and apoptosis. All these ultra-
structural changes represent their reduced functional capacity 
and AR. 
Conclusions. We have shown a link between Pl ultrastruc-
tural degeneration which reflects their aspirin resistance and 
depends on IHD risk factors. We also have found for the first 
time that the clinical evidence of AR correlates with the pres-
ence of Pl destruction, their increased adhesive properties, 
cytoplasm vacuolization and tendency to apoptosis. 
The interrelationship between 
the coronary heart disease’s course 
and community-acquired pneumonia 
(the retrospective analysis data)
N.S. Mykhailovska, Т.О. Kulynych, V.A. Morguntsov
Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine
Objective – to investigate the effect of the community-
acquired pneumonia on the clinical course of coronary heart 
disease and the frequency of major cardiovascular events inci-
dence based on the retrospective analysis results.
Methods. The retrospective analysis of 203 case histories 
of patients with CHD (median age 73 years (63.00, 80.50), 
score on the PSI/PORT – 80 (69; 93)), hospitalized in the 
therapeutic department because of CAP was performed. The 
study of the main cardiovascular events was conducted with 
each patient or his relatives through telephone conversations. 
The data on readmission and reference of the patient to medi-
cal institutions in the consequence of arrhythmic complica-
tions, progression of heart failure, destabilization of coronary 
artery disease within 1 year after the transmitted pneumonia 
were considered. By cumulative endpoint attributed all fatal 
and nonfatal cardiovascular events that occurred during the 
year after CAP.
Results. In total, in patients with CHD during 1 year after 
the transferred CAP 104 cardiovascular events were recorded, 
37 (18.23 %) patients needed the re-hospitalization. The most 
common causes of health aggravation in patients with CHD 
after CAP were the rhythm and conduction abnormalities, the 
occurrence or decompensation of preexisting heart failure and 
deterioration of angina pectoris. Of the hospitalized patients, 
20 (62.5 %) had a combination of 2 or more of the complica-
tions noted. The development of acute myocardial infarction 
was observed in 3 (1.48 %) patients at 7 and 9 days from the 
moment of admission for hospitalization. The arrhythmias, 
acute myocardial infarction and decompensation of heart fail-
ure were observed with the same frequency in patients of all 
groups, regardless of the severity of pneumonia and the risk of 
mortality on the PSI/PORT scale. There were not found the 
impact on the development of adverse cardiovascular events in 
patients with CHD after CAP such factors as male gender, 
presence of anamnesis of transmitted MI, arterial hyperten-
sion, angina pectoris III–IV FK, previous arrhythmic disor-
ders, and also such traditional factors as smoking and diabetes 
mellitus.
Conclusions. The community-acquired pneumonia exerts 
an adverse effect on the clinical course of coronary heart dis-
ease by increasing the functional class of angina, heart failure 
progress and the development of arrhythmic; the most common 
cause of the lethal outcome in patients with coronary heart 
disease after community-acquired pneumonia is acute heart 
